Safety and immunogenicity of high molecular weight polysaccharide vaccine from immunotype 1 Pseudomonas aeruginosa.

The safety and immunogenicity of a high molecular weight polysaccharide from immunotype 1 Pseudomonas aeruginosa were tested in a dose response fashion in adult volunteers. The vaccine lacked toxicity and pyrogenicity for experimental animals. Doses of 50, 75, 150, or 250 microgram were given to gro...

Descripció completa

Dades bibliogràfiques

Publicat a:	J Clin Invest
Autor principal:	Pier, G B
Format:	Artigo
Idioma:	Inglês
Publicat:	American Society for Clinical Investigation 1982
Matèries:	Research Article
Accés en línia:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC370979/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/6799548/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI110453
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!